John S Yu Insider Profile

4 Followers
John S Yu, Director at ImmunoCellular Therapeutics, holds 120.51K shares in ImmunoCellular Therapeutics (Ticker: IMUC).
tipranks
John S Yu

John S Yu
ImmunoCellular Therapeutics (IMUC)
Director

Ranked #81,893 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-34.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14K
100.00%
A breakdown of John S Yu's holdings

Insider Roles

ImmunoCellular Therapeutics
(IMUC)
Director
Roles that John S Yu holds in companies

Most Profitable Insider Trade

Stock:
ImmunoCellular Therapeutics
(IMUC)
Rating:Informative Buy
Date:Oct 22, 2013 - Oct 22, 2014
Return:0.00%
The most profitable trade made by John S Yu

John S Yu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ImmunoCellular Therapeutics
Jun 08, 2018
Director
Uninformative Buy
$13.86K
Success Rate for
IMUC
0 out of 3 profitable transactions on
IMUC
0%
Average Return for
IMUC
Average return per transaction on
IMUC
-34.33%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 25, 2012
Uninformative Buy
-
$1.22K
Nov 27, 2013
Informative Buy
$8.15K
-
$0.25
-81.80%
Nov 27, 2013
Uninformative Buy
$0.00
-
$0.00
Oct 22, 2013
Informative Buy
$66.85K
-
$0.25
0.00%
Oct 22, 2013
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see John S Yu's performance on stock

John S Yu insider profile FAQ

What is the percentage of profitable transactions made by John S Yu?
The percentage of profitable transactions made by John S Yu is 0%.
    What is the average return per transaction made by John S Yu?
    The average return per transaction made by John S Yu is -34.30%.
      What stocks does John S Yu hold?
      John S Yu holds: IMUC stocks.
        What was John S Yu’s latest transaction?
        John S Yu latest transaction was an Uninformative Buy of ―.
          What was John S Yu's most profitable transaction?
          John S Yu’s most profitable transaction was an Informative Buy of IMUC stock on October 22, 2013. The return on the trade was 0.00%.
            What is John S Yu's role in ImmunoCellular Therapeutics?
            John S Yu's role in ImmunoCellular Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.